Kurum Yazarı "Cüre, Osman" Tıp Fakültesi İçin Listeleme
-
Angioedema in a patient with ankylosing spondylitis treated with etanercept
Cüre, Osman; İlkkılıç, Kadir (Türkiye Klinikleri Yayınevi, 2023)Ankylosing spondylitis (AS) is a chronic inflammatory disease of unknown pathogenesis. Nonsteroidal antiinflammatory and biologic drugs are used in its treatment. A 38 year old male patient diagnosed with AS was admitted ... -
Another side of lupus: A case report of lupus presenting with cutaneous vasculitis
Cüre, Osman; İlkkılıç, Kadir (Wiley, 2023)Systemic lupus erythematosus (SLE) is a systemic autoimmune complex disease that affects any organ, characterized by immune complex formation and autoantibody production. Lupus vasculitis begins at a young age. These ... -
The development of ankylosing spondylitis in a patient with familial hemophilia
Cüre, Osman; İlkkılıç, Kadir (Wiley, 2023)Hemophilia is a rare inherited disease which causes bleeding due to Factor VIII or Factor IX deficiency. It is usually X-linked recessive and typically affects males. Arthropathy occurs as a result of cartilage damage and ... -
The effect of anti-tumor necrosis factor therapy on the plasma atherogenic index in rheumatic diseases
Cüre, Osman; Kızılkaya, Bayram; Çiftel, Serpil; Mercantepe, Filiz (Mary Ann Liebert Inc., 2024)Background: The risk of atherosclerosis is increased in individuals with rheumatological disease. The objective of this study is to examine the heightened susceptibility to atherosclerosis in persons afflicted with ... -
Effect of fibromyalgia on demographic, biochemical, metabolic and inflammatory profiles: a single-centre retrospective study
Cüre, Osman; Kızılkaya, Bayram; Çiftel, Serpil; Klisic, Aleksandra; Çiftel, Enver; Mercantepe, Filiz (Pisa, Italy : Pacini editore, 2024)Objectives: The objective of this study is to ascertain the disparities in demographic features and biochemical profiles between individuals diagnosed with fibromyalgia (FM) and a control group of healthy individuals. Methods: ... -
An example of a comprehensive approach to increase the access to evidence-based tobacco cessation support for smokers with rheumatic diseases
Cüre, Osman; Karadoğan, Dilek; Telatar, Tahsin Gökhan; İlkkılıç, Kadir (European Publishing, 2023)INTRODUCTION For a comprehensive approach to adult smoking cessation, contributions by all physicians are more relevant than individual efforts. This study is an example of a collaboration that aims to increase access to ... -
An example of comprehensive approach to tobacco cessation: Collaboration with Rheumatology Clinic
Cüre, Osman; Karadoğan, Dilek; Telatar, Tahsin Gökhan; İlkkılıç, Kadir (European Respiratory, 2023)Background and aim: For a comprehensive approach to adult smoking cessation, all physicians' contribution is much more relevant than the individual efforts. This study aims to evaluate the effectiveness of brief cessation ... -
Hepatitis B reactivation risk and physician awareness in rheumatological patients receiving anti-tumor necrosis factor-α treatment
Cüre, Osman; Kızılkaya, Bayram; Durak, Serdar; İlkkılıç, Kadir (Assoc Medica Brasileira, 2024)OBJECTIVE: We aimed to evaluate the risk of hepatitis B virus reactivation in rheumatic patients using anti-tumor necrosis factor-alpha drugs and the awareness of physicians about hepatitis B virus reactivation. METHODS: ... -
Inflammatory polyarthritis induced by nivolumab treatment in a patient with malignant melanoma: A case report
Cüre, Osman; İlkkılıç, Kadir; Altuner, Mehmet Şakir (İnönü Üniversitesi Tıp Fakültesi, 2023)Nivolumab is a monoclonal antibody that inhibits the programmed death ligand 1 from binding with PD-1 and restricts T-cell inactivation against cancer cells. After the introduction of nivolumab, in addition to its known ... -
Occupational risks and safety precautions for COVID-19 in workers with rheumatic diseases
Sandal, Abdulsamet; Karadoğan, Dilek; Töreyin, Zehra Nur; Cüre, Osman; Akgün, Metin (Lippincott Williams & Wilkins, 2020)Coronavirus disease 2019 (COVID-19) has spread worldwide rapidly and was declared a pandemic on March 11, 2020, by the World Health Organization.